These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct. Sugimoto M, Elliott IA, Nguyen AH, Kim S, Muthusamy VR, Watson R, Hines OJ, Dawson DW, Reber HA, Donahue TR. JAMA Surg; 2017 Jan 18; 152(1):e163349. PubMed ID: 27829085 [Abstract] [Full Text] [Related]
8. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas. Hirono S, Kawai M, Okada KI, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H. JAMA Surg; 2017 Mar 15; 152(3):e165054. PubMed ID: 28122068 [Abstract] [Full Text] [Related]
9. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. J Clin Gastroenterol; 2006 Oct 15; 40(9):856-62. PubMed ID: 17016145 [Abstract] [Full Text] [Related]
10. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm. Zhang J, Wang PJ, Yuan XD. Eur J Radiol; 2010 Jan 15; 73(1):96-101. PubMed ID: 19008065 [Abstract] [Full Text] [Related]
13. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I, Inayama Y, Maeda S, Nakajima A, Kubota K. Pancreatology; 2012 Jan 15; 12(2):141-5. PubMed ID: 22487524 [Abstract] [Full Text] [Related]